ClinicalTrials.govpublic full text
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
elevated lipoprotein(a) level, coronary artery disease, drug-eluting stent, dual antiplatelet therapy, lipoprotein(a), percutaneous coronary intervention, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 834094
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.